title: Nutritional supplements for dry eye syndrome.
abstract: OBJECTIVE
  Essential fatty acids have been of interest in the treatment of systemic and ocular diseases, and is most recently of interest in the area of dry eye disease.
  
  
  RESULTS
  Systemic and topical omega-3 fatty acids and omega-6 fatty acids have been used recently as an adjunctive treatment for patients with dry eye disease. They appear to have efficacy against the symptoms of dry eye that many patients experience. This symptom is postulated to be secondary to the anti-inflammatory effects that have been previously described. Although this effect is promising, more investigation is warranted in order to standardize indication for use, and composition and dosing for treatment.
  
  
  CONCLUSIONS
  The use of essential fatty acids as a nutritional supplement is a novel treatment for patients with dry eye syndrome.
authors: Mount Sinai School of Medicine, New York, NY 10029, USA.
authors: Allison L
authors: AL
authors: Rand
authors: Penny A
authors: PA
authors: Asbell
references: Ocul Surf. 2010 Jan;8(1):18-28
references: 20105404
references: Arch Ophthalmol. 2006 Jul;124(7):995-1001
references: 16832023
references: Evid Rep Technol Assess (Summ). 2005 Jul;(117):1-6
references: 16111433
references: Annu Rev Immunol. 2007;25:101-37
references: 17090225
references: Ophthalmology. 2006 Jul;113(7):1165-72; quiz 1172-3, 1178
references: 16815401
references: Trans Am Ophthalmol Soc. 2008;106:336-56
references: 19277245
references: Biomed Pharmacother. 2002 Oct;56(8):365-79
references: 12442909
references: Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):157-63
references: 19008087
references: Ocul Surf. 2007 Apr;5(2):75-92
references: 17508116
references: Ocul Surf. 2007 Apr;5(2):179-93
references: 17508121
references: Nat Med. 2010 May;16(5):592-7, 1p following 597
references: 20383154
references: Cornea. 2003 Mar;22(2):97-101
references: 12605039
references: Cleve Clin J Med. 2004 Mar;71(3):208-10, 212, 215-8 passim
references: 15055244
references: Arch Ophthalmol. 2008 Jun;126(6):826-33
references: 18541848
references: Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4474-9
references: 16303936
references: Cont Lens Anterior Eye. 2008 Jun;31(3):141-6; quiz 170
references: 18313350
references: Am J Clin Nutr. 2000 Jan;71(1 Suppl):179S-88S
references: 10617969
references: Ocul Surf. 2007 Apr;5(2):163-78
references: 17508120
references: JAMA. 2006 Oct 18;296(15):1885-99
references: 17047219
references: Evid Rep Technol Assess (Summ). 2005 Aug;(118):1-11
references: 16194124
references: Ocul Surf. 2007 Apr;5(2):153-62
references: 17508119
references: Postgrad Med. 2008 Jul;120(2):92-100
references: 18654074
references: J Fr Ophtalmol. 2006 Oct;29(8):868-73
references: 17075501
references: J Physiol. 2007 Jan 15;578(Pt 2):397-411
references: 17038422
references: CMAJ. 2008 Jan 15;178(2):150
references: 18195286
references: Circulation. 2002 Nov 19;106(21):2747-57
references: 12438303
references: Exp Biol Med (Maywood). 2008 Jun;233(6):674-88
references: 18408140
references: Ocul Surf. 2007 Apr;5(2):108-52
references: 17508118
references: Ocul Surf. 2007 Apr;5(2):93-107
references: 17508117
references: Arch Ophthalmol. 2008 Feb;126(2):219-25
references: 18268213
references: Biosci Biotechnol Biochem. 1998 Nov;62(11):2079-85
references: 9972229
references: Retina. 2007 Feb;27(2):216-21
references: 17290205
references: Environ Res. 2004 Jul;95(3):414-28
references: 15220075
references: Eye (Lond). 1998;12 ( Pt 1):127-33
references: 9614529